1. Home
  2. LEGN vs AEIS Comparison

LEGN vs AEIS Comparison

Compare LEGN & AEIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AEIS
  • Stock Information
  • Founded
  • LEGN 2014
  • AEIS 1981
  • Country
  • LEGN United States
  • AEIS United States
  • Employees
  • LEGN N/A
  • AEIS N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AEIS Industrial Machinery/Components
  • Sector
  • LEGN Health Care
  • AEIS Technology
  • Exchange
  • LEGN Nasdaq
  • AEIS Nasdaq
  • Market Cap
  • LEGN 6.3B
  • AEIS 5.9B
  • IPO Year
  • LEGN 2020
  • AEIS 1995
  • Fundamental
  • Price
  • LEGN $31.46
  • AEIS $173.57
  • Analyst Decision
  • LEGN Strong Buy
  • AEIS Buy
  • Analyst Count
  • LEGN 12
  • AEIS 10
  • Target Price
  • LEGN $73.36
  • AEIS $140.70
  • AVG Volume (30 Days)
  • LEGN 1.2M
  • AEIS 412.8K
  • Earning Date
  • LEGN 11-11-2025
  • AEIS 10-29-2025
  • Dividend Yield
  • LEGN N/A
  • AEIS 0.23%
  • EPS Growth
  • LEGN N/A
  • AEIS N/A
  • EPS
  • LEGN N/A
  • AEIS 2.22
  • Revenue
  • LEGN $796,838,000.00
  • AEIS $1,635,742,000.00
  • Revenue This Year
  • LEGN $69.31
  • AEIS $19.29
  • Revenue Next Year
  • LEGN $52.73
  • AEIS $7.24
  • P/E Ratio
  • LEGN N/A
  • AEIS $78.06
  • Revenue Growth
  • LEGN 74.75
  • AEIS 8.49
  • 52 Week Low
  • LEGN $27.34
  • AEIS $75.01
  • 52 Week High
  • LEGN $51.77
  • AEIS $180.90
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 31.45
  • AEIS 60.30
  • Support Level
  • LEGN $32.02
  • AEIS $172.91
  • Resistance Level
  • LEGN $32.62
  • AEIS $180.90
  • Average True Range (ATR)
  • LEGN 1.02
  • AEIS 6.23
  • MACD
  • LEGN -0.09
  • AEIS 0.08
  • Stochastic Oscillator
  • LEGN 6.87
  • AEIS 61.64

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.

Share on Social Networks: